advertisement
Bejanian M 10
Showing records 1 to 10 |
Display all abstracts from Bejanian M79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target TissuesSeal JR
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 StudiesWeinreb RN; Liebmann JM
Ophthalmology 2018; 125: 1874-1885
79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target TissuesRobinson MR; Burke J
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 StudiesCioffi GA
Ophthalmology 2018; 125: 1874-1885
79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target TissuesBejanian M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 StudiesGoldberg I
Ophthalmology 2018; 125: 1874-1885
79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target TissuesCoote M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 StudiesBrandt JD
Ophthalmology 2018; 125: 1874-1885
79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target TissuesAttar M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 StudiesJohnson CA; Zangwill LM; Schneider S; Badger H; Bejanian M
Ophthalmology 2018; 125: 1874-1885